Success Stories: A Research Assistant Professor from India Secures NIW as well as EB1A Petition Approvals 5 Months Apart with Our Diligent Team’s Efforts
Client’s Testimonial:
“I am extremely satisfied with the services of Wegreend Chen immigration groups for the preparation of my green card petition letter. Their guidance helped me to submit my petition letter successfully to USCIS. They are very helpful and critically reviewed all the documents. I am very happy with their services.”
On July 27th, 2022 and December 5th, 2022, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Research Assistant Professor in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Research Assistant Professor
Country of Origin: India
Approval Notice Date: July 27th, 2022 (NIW) and December 5th, 2022 (EB-1A)
Processing Time: 6 months, 4 days (NIW) and 9 months (EB-1A) (Premium Processing Requested)
Case Summary:
A research assistant professor engaged the unprecedented service of North America Immigration Law Group to help her file an I-140 NIW (National Interest Waiver) petition on her behalf, and while her NIW case was in adjudicating process, she decided to retain us for filing another petition under EB-1A (Alien of Extraordinary Ability) visa category. Initially, we worked on her EB-2 NIW petition and then started working on her EB1A case.
To make our client’s NIW and EB1A a success, we evaluated her research and its interests in the United States. Our goal was to prove her unmatched skills relevant to her current and future work which indicates that she qualifies for both the national interest waiver as well as an alien of extraordinary ability visa categories.
We incorporated the following details in her petition packets:-
- We noted that she held a Ph.D. in biochemistry, and her research focused on leishmaniasis, a parasitic disease, seeking to develop novel treatment strategies in response to reduced efficacy from current therapeutics. We concluded that her research into the disease processes of infection, inflammation, carcinogenesis, and hypertension addresses some of our nation’s and the world’s most pressing issues.
- Her strong background in mucosal immunology has allowed her research to be particularly original, resulting in her success in fundamentally transforming the scientific community’s understanding of disease processes of infection, inflammation, carcinogenesis, and hypertension. She is particularly well-known for her contributions to developing improved treatment for leishmaniasis in the form of a plant-based immunomodulatory therapy.
- Additionally, we highlighted the 1,901 citations accumulated from 48 peer-reviewed scientific articles and 1 editorial she published in some of the prominent journals in her field and have been cited by researchers at least in 76 countries, affirming how these publications are widely recognized and relied upon in the field of immunology.
- Besides, we observed that she had also conducted 30 reviews for highly acclaimed journals. In addition to her work as a peer reviewer, she sits on the editorial board of physiological genomics, further demonstrating that she satisfies the criterion of showing that the petitioner has served on an editorial board similarly establishes that the petitioner has served as a judge of the work of others.
“[Client’s] work treating leishmaniasis has allowed her to hone her use of important skills that proved instrumental in the success of her later research on inflammatory bowel diseases, such as flow cytometry and cell sorting. Furthermore, the treatment methods she developed for leishmaniasis have applications that extend beyond the treatment of one disease. When conducting her research, she does not simply set out to solve a singular problem in the interest of publishing a paper. She seeks to broaden the corpus of scientific knowledge and bring the utility of often-overlooked products, such as berberine and artemisinin, to light. The field of immunology is enriched by her participation, and I am proud to offer my support of her continued research in the United States.”
To summarize, our client exhibits a level of expertise that positions her at the top of the immunological scientific community in the United States.
Gladly, the adjudicating authorities of USCIS were convinced that our client has proven herself to be an incredibly resourceful researcher. We are happy that our efficiency and diligence in our client’s respective cases led her to NIW and EB-1A approvals. Since our client upgraded her EB-1A petition to Premium Processing Service, her case got approved 12 days after the PP request was submitted. We congratulate her on achieving this milestone and thank her for trusting our law firm to be a part of this phenomenal victory.